Prostate Cancer

Prostate cancer is the most common malignancy diagnosed in North American men (other than skin cancer). One out of every 6 to 7 men will develop the disease during his lifetime. The exact cause of prostate cancer is still unknown; however, a combination of genetic, nutritional and environmental factors appear to play a role in its development. Typically, prostate cancer begins in the outer part of the gland. When confined within the prostate, it is called localized prostate cancer. Prostate cancer may behave in many different ways in different men. It may be relatively slow growing, but it may also be more aggressive in its behavior with a tendency to metastasize or spread to the lymph nodes, bones, or other parts of the body. It is this latter form of prostate cancer that is life threatening.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

It's A Snow Day

It's A Snow Day: Friday March 8

It's A Snow Day at Mt. Seymour, a fundraiser for Prostate Cancer Foundation BC, is being held on Friday March 8, 2019. Visit the event website for more details, and to register and/or sponsor a participant, or donate directly to Prostate Cancer Foundation BC.

10th Anniversary Ride to Live

West Coast Motorcycle Ride To Live: May 26th

The 10th Anniversary West Coast Motorcycle Ride to Live is taking place in Vancouver and the Fraser Valley on May 26 (Victoria date to be finalized), with details on the event and how to register on the event website.  This fundraiser for Prostate Cancer Foundation BC includes a 50/50 raffle open to all BC residents over age 19.

Employment

Work at the Vancouver Prostate Centre

Tuesday, November 27, 2018

An innovative new study advances personalized medicine for prostate cancer patients

Drs Chi and Wyatt
Tuesday, October 23, 2018

Three researchers receive Prostate Cancer Canada & Movember Foundation grants for biomarker development